These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29680700)

  • 1. Early Surgical Intervention is Beneficial in Avoiding Complications in Patients with Male Lower Urinary Tract Symptoms.
    Bachmann A; Rapoport LM; Wetterauer C
    Eur Urol Focus; 2018 Jan; 4(1):2-3. PubMed ID: 29680700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utilization of Benign Prostatic Hyperplasia and Bladder-Related Medications After a Transurethral Prostatectomy.
    Campbell J; Reid J; Ordon M; Welk B
    Urology; 2019 Aug; 130():126-131. PubMed ID: 31129193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of benign prostatic hyperplasia.
    Nunes RV; Manzano J; Truzzi JC; Nardi A; Silvinato A; Bernardo WM;
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):95-99. PubMed ID: 28355368
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
    Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
    Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Pham H; Sharma P
    Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of benign prostatic hyperplasia.
    Pinheiro LC; Martins Pisco J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment options for benign prostatic hyperplasia and their impact on sexual function.
    Larson TR
    Urology; 2003 Apr; 61(4):692-8. PubMed ID: 12670545
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
    Schauer I; Madersbacher S
    Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.
    Cindolo L; Pirozzi L; Fanizza C; Romero M; Tubaro A; Autorino R; De Nunzio C; Schips L
    Eur Urol; 2015 Sep; 68(3):418-25. PubMed ID: 25465970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Blockers, 5-α-Reductase Inhibitors, Acetylcholine, β3 Agonists, and Phosphodiesterase-5s in Medical Management of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: How Much Do the Different Formulations Actually Matter in the Classes?
    Chughtai B; Thomas D; Kaplan S
    Urol Clin North Am; 2016 Aug; 43(3):351-6. PubMed ID: 27476127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's New in Aquablation.
    Lee R; Roehrborn C
    Eur Urol Focus; 2018 Jan; 4(1):28-31. PubMed ID: 29748094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study.
    Gravas S
    Eur Urol; 2015 Aug; 68(2):338-9. PubMed ID: 26149729
    [No Abstract]   [Full Text] [Related]  

  • 13. Adherence to therapy for lower urinary tract symptoms: don't mistake association with causation!
    Penson DF
    Eur Urol; 2015 Sep; 68(3):426-7. PubMed ID: 25703576
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
    Sarma AV; Wei JT
    N Engl J Med; 2012 Jul; 367(3):248-57. PubMed ID: 22808960
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment for benign prostatic hyperplasia: Where do we stand?
    Rossanese M; Crestani A; Inferrera A; Giannarini G; Bartoletti R; Tubaro A; Ficarra V
    Urologia; 2019 Aug; 86(3):115-121. PubMed ID: 31282310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy for benign prostatic hyperplasia: a review.
    Van Asseldonk B; Barkin J; Elterman DS
    Can J Urol; 2015 Oct; 22 Suppl 1():7-17. PubMed ID: 26497339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Trends in the Management of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
    Mahon JT; Welliver C
    Curr Urol Rep; 2020 Nov; 21(12):63. PubMed ID: 33210174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.